Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

WuXi Biologics Sets March 24 Board Meeting to Approve 2025 Annual Results

Tipranks - Tipranks - Wed Feb 11, 5:54PM CST

Valentine's Day Sale - 70% Off

An update from Wuxi Biologics (Cayman) ( (HK:2269) ) is now available.

WuXi Biologics (Cayman) Inc. has scheduled a board meeting for March 24, 2026 to review and approve the group’s annual results for the financial year ended December 31, 2025. The approval and subsequent publication of these results will provide investors and other stakeholders with updated insight into the company’s financial performance and operational progress over the past year.

The board, chaired by Dr. Ge Li and comprising executive, non-executive and independent non-executive directors, will also address other matters at the meeting. The announcement signals the start of the company’s formal annual reporting cycle, a key event for market participants tracking WuXi Biologics’ growth and strategic direction in the biopharmaceutical services industry.

The most recent analyst rating on (HK:2269) stock is a Hold with a HK$39.00 price target. To see the full list of analyst forecasts on Wuxi Biologics (Cayman) stock, see the HK:2269 Stock Forecast page.

More about Wuxi Biologics (Cayman)

WuXi Biologics (Cayman) Inc. is a contract research, development and manufacturing organization in the biopharmaceutical sector. The group provides biologics development and manufacturing services to global pharmaceutical and biotechnology clients, supporting the discovery, development and commercialization of biologic drugs across international markets.

Average Trading Volume: 34,829,314

Technical Sentiment Signal: Buy

Current Market Cap: HK$155.9B

See more insights into 2269 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).